SCHEMBL12469237

SCHEMBL12469237

O=CCc1ccc(-c2ccncc2)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.56
▸ HDAC3 O15379 1/20 0.47
▸ HDAC4 P56524 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ HDAC11 Q96DB2 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ HDAC9 Q9UKV0 1/20 0.47
▸ HDAC5 Q9UQL6 1/20 0.47
▸ CYP2A6 P11509 10/20 0.42
▸ CYP2C19 P33261 8/20 0.42
▸ CYP2E1 P05181 7/20 0.42
▸ CYP2C9 P11712 7/20 0.42
▸ CYP2D6 P10635 6/20 0.42
▸ CYP2B6 P20813 6/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513272 0.81 CYP2A6 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4551879 0.78 PRF1 (0.42) PRKCIHDAC4HDAC1HDAC6CYP2A6
SCHEMBL13361821 0.76 CYP2E1 (0.36) PRKCICYP2A6CYP2C19CYP2E1CYP2C9
SCHEMBL20388926 0.76 PRKCI (0.66) PRKCIHDAC3HDAC4HDAC1HDAC7
SCHEMBL31467963 0.73 — —
SCHEMBL7751921 0.73 MAPT (0.56) PRKCIHDAC3HDAC4HDAC1HDAC7
SCHEMBL18866660 0.73 PRKCI (0.62) PRKCIHDAC3HDAC4HDAC1HDAC7
SCHEMBL31305759 0.72 APP (0.58) HDAC3HDAC1HDAC2HDAC8CYP2A6
SCHEMBL572604 0.72 CYP2A6 (0.66) PRKCIHDAC3HDAC4HDAC1HDAC7
SCHEMBL9887886 0.71 PRKCI (0.60) PRKCIHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627181-A2 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-08-21 — — EP disclosed
WO-2012051410-A2 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 — — WO disclosed
Send feedback